STUB1 and metabolic dysfunction-associated steatotic liver disease: However, in spite of this concatenation of nonalcoholic fatty liver disease (NAFLD)/NASH-like events, little evidence of NAFLD/NASH, as signaled by its hallmark macrovesicular steatosis, was actually found in CHIP−/−-livers over the first 8–9 months of life.